United States · 
Who invested in Vivatides Therapeutics?
Vivatides Therapeutics's investors include Qiming Venture Partners, Highlight Capital, Apricot Capital and TF Capital. Qiming Venture Partners led its latest round.
20252026
$10MSeed$54MSeries AUnited States · Series A startup
Who invested in Vivatides Therapeutics
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Follow Vivatides Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$64Mraised across 2 rounds since 2025, from 2 sources
$10MSeed$54MSeries A
- Latest round
- Series A, $54MMay 2026
- Led by
- Qiming Venture Partners
- Step-upi
- 5.4×
- Investors
- 4 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $10M Feb 2025
- Biggest round
- $54M Series A · May 2026
- Between rounds
- 15 months from the last two
The rounds
- May 2026Series A$54M3 new1 returning
Reported by Ventureburn
- Feb 2025
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Vivatides Therapeutics
How much has Vivatides Therapeutics raised?
Vivatides Therapeutics has raised $64M across 2 rounds since 2025.
When did Vivatides Therapeutics last raise?
Vivatides Therapeutics's most recent round was a Series A of $54M in May 2026, led by Qiming Venture Partners.
What was Vivatides Therapeutics's biggest round?
Its most recent round, $54M in May 2026, is also its largest on record.
Who backed Vivatides Therapeutics first?
Vivatides Therapeutics's first round on record, in Feb 2025, was backed by Qiming Venture Partners.
What stage is Vivatides Therapeutics at?
Vivatides Therapeutics's latest named round is a Series A, in May 2026.
Where is Vivatides Therapeutics based?
Vivatides Therapeutics is based in the United States.
Who led Vivatides Therapeutics's rounds?
Qiming Venture Partners led the Series A in 2026.
Companies like Vivatides Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.